Login
Toggle navigation
Videos
Categories
Trending
Thoughts on gaming in crypto, NFTs, work-life balance and more|Ramnik Arora,Head of Product,FTX
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Founder of Toy Ventures. Attended Stanford University.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Analyzing Growth and Value Trends: Insights from Josef Lakonishok | Josef Lakonishok, CEO, LSV Asset Management.
00:10:00
The GEOPAR Group was present at the 2023 Gold Symposium | Joao Luiz Nogueira Carvalho, CEO, GEOSOL - Geologia e Sondagens S/A (TS)
00:10:00
Key Economic Trends from Q1 2024 |Christine A. Centeno, Founder, Simplicity Wealth Management LLC.
00:10:00
Doron Blachar Discusses Pandemic's Impact on Ormat Technologies' Operations | Doron Blachar, CEO , Ormat Technologies, Inc.
00:10:00
Resilience and Growth: Martin Vohánka on Eurowag's 25-Year Journey from Private to Public | Martin Vohánka, CEO, W.A.G. Payment Solutions PLC.
00:10:00
AirAsia CEO Tony Fernandes Reveals Secrets to Building a Multi-Billion Dollar Low-Cost Airline | Tony Fernandes, CEO, AirAsia Bhd.
00:10:00
In-Depth Fund Ratings: Morningstar’s View on Artemis UK Smaller Companies and Key Global Funds | Jonathan Miller - Director of Manager Research, UK, Morningstar
00:10:00
investing in their professional & personal growth|Sarah Hodges,Partner,Pillar VC
00:10:00
Central Banks' Focus: Tackling Inflation Through Interest Rate Adjustments|E L (Lesetja) Kganyago,GOVERNOR,South African Reserve Bank
00:10:00
To Buy or Rent: Making the Right Housing Decision | Financial Design Studio
00:10:00
CEO Steve McQuillan & CFO Stephen King Discuss Avingtrans' Upbeat H1 Results | Steve McQuillan - Chief Executive Officer of Avingtrans
00:10:00
Eurazeo's Strategic Shift: Adapting Amid Sector Dislocations and Embracing Sustainability Goals | Virginie Morgon, CEO, Eurazeo.